Howard Aaron Israel, M.D. Allergy & Immunology - Clinical & Laboratory Immunology Medicare: Not Enrolled in Medicare Practice Location: 1605 N Cedar Crest Blvd, Suite 605, Allentown, PA 18104 Phone: 610-820-9000 Fax: 610-820-9078 |
Harold Kreithen, MD Allergy & Immunology - Allergy Medicare: Not Enrolled in Medicare Practice Location: 401 N 17th St, Suite 211, Allentown, PA 18104 Phone: 610-437-0711 Fax: 610-437-9265 |
Nina M Poliak, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1627 Chew St, Allentown, PA 18102 Phone: 610-969-4300 Fax: 610-969-4332 |
Dr. Robert Marc Zemble, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1605 N Cedar Crest Blvd Ste 605, Allentown, PA 18104 Phone: 610-820-9000 Fax: 610-820-9078 |
Dr. William A. Tuffiash, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1251 S Cedar Crest Blvd, Suite 107c, Allentown, PA 18103 Phone: 610-439-8171 Fax: 610-439-8170 |
Dr. Michael David Ciliberti, M.D. Allergy & Immunology - Clinical & Laboratory Immunology Medicare: Accepting Medicare Assignments Practice Location: 250 Cetronia Rd, Suite 103, Allentown, PA 18104 Phone: 610-841-3890 Fax: 610-841-3880 |
Neil Howard Feldman, DO Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 401 N 17th St, Suite 211, Allentown, PA 18104 Phone: 610-437-0711 Fax: 610-437-9265 |
Miae Oh, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1728 W Jonathan St Ste 100, Allentown, PA 18104 Phone: 610-628-1225 |
News Archive
Scientists have created a new molecule that shows promise for controlling HIV without daily antiretroviral drugs. The molecule foils a wider range of HIV strains in the laboratory than any known broadly neutralizing HIV antibody and is more powerful than some of the most potent of these antibodies.
Scientists at the Immunology Frontier Research Center at Osaka University, Japan have pinpointed a specific molecular events that could explain allergic reactions to air pollution.
Patients with chronic myeloid leukaemia who use the tyrosine kinase inhibitor imatinib may be three to four times more likely to develop non-Hodgkin's lymphoma than the general population, study findings indicate.
The American Cancer Society's 2013 Cancer Statistics report found that the incidence of melanoma continues to rise in both men and women. This is particularly concerning because skin cancer can often be easily prevented and detected.
› Verified 3 days ago